Skip to main content
. 2019 Oct 7;25(37):5590–5603. doi: 10.3748/wjg.v25.i37.5590

Figure 4.

Figure 4

Overall survival and relapse-free survival evaluated between pancreatic cancer patients with high and low expression of ADAM28. A: OS of pancreatic cancer patients from TCGA; B: RFS of pancreatic cancer patients from TCGA; C: OS of pancreatic cancer patients with high TMB between the high and low ADAM28 expression cohorts; D: OS of pancreatic cancer patients with low TMB between the high and low ADAM28 expression cohorts. OS: Overall survival; RFS: Relapse-free survival; TMB: Tumor mutation burden; TCGA: The Cancer Genome Atlas.